Trial Profile
A multicenter global named patient program (NPP) for Ibrutinib in patients with Mantle-Cell Lymphoma : a real world study
Status:
Completed
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 13 Sep 2016
Price :
$35
*
At a glance
- Drugs Ibrutinib (Primary)
- Indications Mantle-cell lymphoma
- Focus Therapeutic Use
- 13 Sep 2016 New trial record